The Transport of a Hepatoprotective Agent Isopropryl 2-(1-3- dithiethane-2-ylidene)-2[N-(4-methyl-thiazole-2-yl) carbamoyl] Acetate (YH439), across Caco-2 Cell Monolayers

Archives of Pharmacal Research

Volumn 24, Issue 6, 2001, Pages 584-589

  Park, Hyeon Woo ^a   Chung, Suk Jae ^a   Lee, Myung Gull ^a   Shim, Chang Koo ^a  

^a Seoul National University   (South Korea)

Author keywords

Bioavailability; Caco 2 cells; Saturation; Solubilization; Transport; YH439

Indexed keywords

2 (1,3 DITHIETAN 2 YLIDENE) 2 [N (4 METHYL 2 THIAZOLYL)CARBAMOYL]ACETIC ACID ISOPROPYL ESTER; THIAZOLE DERIVATIVE;

ARTICLE; BIOAVAILABILITY; CELL STRAIN CACO 2; CHEMISTRY; HUMAN; LIVER; METABOLISM; SOLUBILITY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CACO-2 CELLS; HUMANS; LIVER; SOLUBILITY; THIAZOLES;

EID: 0035748818     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975170     Document Type: Article

References (11)

1. Artursson, P. and Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Comm., 175, 880-885 (1991).
2. Augustijns, P. F., Bradshaw, T. P., Gan, L-S.L., Hendren, R. W., and Thakker, D. R. Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport. Biochem. Biophys. Res. Commun., 197, 360365. (1993)
3. Choi, E. J., Improvement of intestinal absorption of poorly soluble drug, YH439, by mixed micelles, M. S. Thesis, College of Pharmacy, Seoul National University, Seoul, Korea (1994).
4. Choi, E. Y., Kim, S. G., Lee, J. W., Yoo, J. K., Shin, J. K., and Kim, N. D., Suppression of rat hepatic cytochrome P450 2E1 expreesion by isopropyl 2-(1-3-dithioethane- 2-ylidene)-2[N-(4-methyl-thiazole-2-yl) carbamoyl] acetate (YH439), an experimental hepatoprotectant protective role against hepatic injury. Biochem. Pharmacol., 52, 1219-1225 (1996).
5. Jeong, K. S., Lee, I. J., Roberts, B. J., Soh, Y., Yoo, J. K., Lee, J. W., and Song, B. J., Transcriptional inhibition of cytochrome P4502E1 by a synthetic compound, YH439. Arch. Biochem. Biophys., 326, 137-144 (1996).
6. Kim, H. S., Choi, E. J., Lee, M. G., Lee, J. U., Chung, S. J., Lee, M. H., and Shim, C. K., Increased gastrointestinal absorption of YH439, a novel and sparingly water- soluble hepatoprotective drug, in rats. Proceedings of European Symposium on Formulation of Poorly-available Drugs for Oral Administration, Association De Pharmcie Galenique Industrielle, held on 5/6 February 1996, in Paris, France.
7. Kim, J., Han, K. S., Lee, J. W., and Lee, M. G., Hepatic and intestinal first-effect of a new hepatoprotective agent, YH439, in rats. Res. Comm. Mol. Pathol. Pharmacol., 102, 125-136 (1998).
8. Rubas, W., Cromwell, M. E., Shahrokhk, Z., Villagran, J., Nguyen, T. N., Wellton, M., Nguyen T. H., and Mrsny R. J. Flux measurements across Caco-2 cell monolayers may predict transport in human large intestinal tissue. J. Pharm. Sci., 85, 165-169 (1996)
9. Yee, S., In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm. Res., 14, 763-766 (1997).
10. Yoon, W. H., Park, J. H., Lee, W. I., Lee, J. W., Shim, C. K., and Lee, M. G., Stability and blood partition of YH439: a new hepatoprotective agent, Drug Stab., 1, 106-111 (1996).
11. Yoon, W. H., Yoo, J. K., Lee, J. W., Shim, C. K., and Lee, M. G., Species differences in pharmacokinetics of a hepatoprotective agent, YH439, and its metabolites, M4, M5, and M7, after intravenous and oral administration to rats, rabbits and dogs. Drug Metab. Dispos., 26, 152-163 (1998).